3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
7
Colorectal Neoplasms
4
Breast Neoplasms
4
Small Cell Lung Carcinoma
3
Neoplasms
3
Lung Neoplasms
3
Stomatitis
2
Male Urogenital Diseases
2
Cardiovascular Diseases
2
Carcinoma, Non-Small-Cell Lung
2
Vascular Diseases
1
Ulcer
1
Sexual Dysfunction, Physiological
1
Rectal Neoplasms
1
Radiation-induced Injuries in Patients With Rectal Cancer
1
Radiation Injuries
1
Polycystic Ovary Syndrome
1
Ovarian Neoplasms
1
Non-melanoma Skin Cancer
1
Neurotoxicity Syndromes
1
Myocardial Ischemia
1
Myocardial Infarction
1
Lymphoma, Follicular
1
Heart Diseases
1
Head and Neck Neoplasms
1
Fibrosis
1
Fatigue
1
Eye Diseases
1
Erectile Dysfunction
1
Dyspareunia
1
Interventions
Antineoplastic Agents
3
Nutrition Assessment
2
Echocardiography
2
Blood Specimen Collection
2
liposomal doxorubicin
1
Vitamin E
1
Vital Signs
1
Tomography, X-Ray Computed
1
Tomography, Emission-Computed
1
Therapeutics
1
Surveys and Questionnaires
1
Specimen Handling
1
Positron-Emission Tomography
1
Methods
1
Mass Screening
1
Magnetic Resonance Imaging
1
Interviews as Topic
1
Immunomodulating Agents
1
Immune Checkpoint Inhibitors
1
Hematologic Tests
1
Exercise Test
1
Chemoradiotherapy
1
Case Management
1
Breathing Exercises
1
Atorvastatin
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Heart Diseases
×
Vitamin E
×
Clear all
NCT00000479
2012-06-15
WHS
Brigham and Women's Hospital
Phase 3
Completed
39,876 enrolled
11 charts